Condition
Tuberculosis Prevention
Total Trials
4
Recruiting
2
Active
3
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Recruiting2
Completed1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07762014Phase 2Recruiting
rBCG-N-RSV Vaccine in Adults Aged 60 Years and Older
NCT07628140Not ApplicableRecruitingPrimary
Kulindana: Community-friendly Delivery and Monitoring of TPT to Improve Uptake and Reduce TB Transmission
NCT04557176Not ApplicableActive Not Recruiting
TB Screening Improves Preventive Therapy Uptake
NCT04494516Completed
Qualitative Understanding of Community TB Services Pre and Post the CHIP-TB Trial
Showing all 4 trials